Practice · Artificial Intelligence Leadership and Strategy (AILS)

~/apmg-ails · apmg-ails_d1_8947acbd92ae ▊

← Artificial Intelligence Leadership and Strategy (AILS) · practice sheet

apmg-ails_d1_8947acbd92ae domain/d1 · medium single

A pharmaceutical company wants to increase agility across its business. Its transformation lead argues that manufacturing processes for its regulated medicines should be made just as highly agile as its marketing function. According to the source material, why is this recommendation flawed?

A Agility can only ever be applied to marketing and distribution, never to any production activity
B Different levels of agility capability are expected across a business, and high agility in regulated manufacturing would be highly undesirable
C Manufacturing cannot benefit from agility because Scrum is limited to teams of 10 or fewer members
D Agility should be applied uniformly everywhere, so singling out manufacturing is the real problem

Unlock this exam to join the per-question discussion and vote on questions.

next question →